413 related articles for article (PubMed ID: 30361778)
1. Restriction of drug transport by the tumor environment.
Nandigama R; Upcin B; Aktas BH; Ergün S; Henke E
Histochem Cell Biol; 2018 Dec; 150(6):631-648. PubMed ID: 30361778
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles designed to regulate tumor microenvironment for cancer therapy.
Li M; Zhang F; Su Y; Zhou J; Wang W
Life Sci; 2018 May; 201():37-44. PubMed ID: 29577880
[TBL] [Abstract][Full Text] [Related]
3. Micropharmacology: An In Silico Approach for Assessing Drug Efficacy Within a Tumor Tissue.
Karolak A; Rejniak KA
Bull Math Biol; 2019 Sep; 81(9):3623-3641. PubMed ID: 29423880
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
Muntimadugu E; Kommineni N; Khan W
Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
[TBL] [Abstract][Full Text] [Related]
5. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
Danhier F; Feron O; Préat V
J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
[TBL] [Abstract][Full Text] [Related]
6. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
[TBL] [Abstract][Full Text] [Related]
7. Microenvironmental Niches and Sanctuaries: A Route to Acquired Resistance.
Pérez-Velázquez J; Gevertz JL; Karolak A; Rejniak KA
Adv Exp Med Biol; 2016; 936():149-164. PubMed ID: 27739047
[TBL] [Abstract][Full Text] [Related]
8. The reciprocal interaction: chemotherapy and tumor microenvironment.
Kim SH; Kuh HJ; Dass CR
Curr Drug Discov Technol; 2011 Jun; 8(2):102-6. PubMed ID: 21513484
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
Li W; Sun X
Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
11. Metronomic scheduling of anticancer treatment: the next generation of multitarget therapy?
André N; Padovani L; Pasquier E
Future Oncol; 2011 Mar; 7(3):385-94. PubMed ID: 21417902
[TBL] [Abstract][Full Text] [Related]
12. Improving drug delivery to solid tumors: priming the tumor microenvironment.
Khawar IA; Kim JH; Kuh HJ
J Control Release; 2015 Mar; 201():78-89. PubMed ID: 25526702
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery and transport to solid tumors.
Jang SH; Wientjes MG; Lu D; Au JL
Pharm Res; 2003 Sep; 20(9):1337-50. PubMed ID: 14567626
[TBL] [Abstract][Full Text] [Related]
14. Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment.
Kim BH; Yi EH; Ye SK
Arch Pharm Res; 2016 Aug; 39(8):1085-99. PubMed ID: 27515050
[TBL] [Abstract][Full Text] [Related]
15. A hybrid cellular automaton model of solid tumor growth and bioreductive drug transport.
Kazmi N; Hossain MA; Phillips RM
IEEE/ACM Trans Comput Biol Bioinform; 2012; 9(6):1595-606. PubMed ID: 23221082
[TBL] [Abstract][Full Text] [Related]
16. Phytomedicine-Modulating oxidative stress and the tumor microenvironment for cancer therapy.
Cheng YT; Yang CC; Shyur LF
Pharmacol Res; 2016 Dec; 114():128-143. PubMed ID: 27794498
[TBL] [Abstract][Full Text] [Related]
17. Barriers to drug delivery in interventional oncology.
Sheth RA; Hesketh R; Kong DS; Wicky S; Oklu R
J Vasc Interv Radiol; 2013 Aug; 24(8):1201-7. PubMed ID: 23735316
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in drug delivery systems for enhancing drug penetration into tumors.
He B; Sui X; Yu B; Wang S; Shen Y; Cong H
Drug Deliv; 2020 Dec; 27(1):1474-1490. PubMed ID: 33100061
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma.
Liu Y; Zhou J; Li Q; Li L; Jia Y; Geng F; Zhou J; Yin T
Adv Drug Deliv Rev; 2021 May; 172():80-103. PubMed ID: 33705874
[TBL] [Abstract][Full Text] [Related]
20. Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response.
Gilabert-Oriol R; Ryan GM; Leung AWY; Firmino NS; Bennewith KL; Bally MB
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
